NCT01801059

Brief Summary

This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and number of completed screening tests for colorectal cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
284

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 28, 2013

Completed
Last Updated

October 16, 2014

Status Verified

October 1, 2014

Enrollment Period

2.9 years

First QC Date

February 26, 2013

Last Update Submit

October 14, 2014

Conditions

Keywords

colon cancerColorectal Cancer Screening

Outcome Measures

Primary Outcomes (1)

  • Completion rate of CRC screening

    A test of two proportions will be used. If the two groups are different at baseline with respect to key covariates, then a logistic regression model will be used to assess the effect of the intervention on CRC screening controlling for possible confounding variables. The variables that differ between the two groups will be tested as confounders using risk-factor modeling. Summary statistics will be used to describe the time point that subjects receive CRC screening, either after the medical visit or after telephone barriers counseling, and relevant comparisons made.

    Up to 2 months

Study Arms (2)

Arm I education CRC and CRC screening

ACTIVE COMPARATOR

Educational intervention: Patients receive CRC and CRC screening information from an educational video and received a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Other: educational interventionOther: questionnaire administration

Arm II education and patient activation intervention

EXPERIMENTAL

Educational intervention administered: Patients receive patient activation intervention comprising CRC and CRC screening information and communication skills training intervention by educational video and brochure, and they also receive a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Other: educational interventionOther: questionnaire administration

Interventions

Receive patient activation intervention by educational video and brochure

Also known as: intervention, educational
Arm I education CRC and CRC screeningArm II education and patient activation intervention

Ancillary studies

Arm I education CRC and CRC screeningArm II education and patient activation intervention

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is 50+ years of age
  • Patient is in need of CRC screening
  • Patient is in good health (e.g. no contraindications to having CRC screening, such as a history of colorectal cancer, congenital heart failure, renal failure, dialysis, dementia, severe arthritis, etc.)
  • Patient is not pregnant
  • Patient is able to speak, read, and understand English

You may not qualify if:

  • Patient is within CRC screening guidelines
  • Patient is at high risk for CRC
  • Patient cannot understand English
  • Patient cannot complete a CRC screening test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Columbus, Ohio, 43210, United States

Location

Related Links

MeSH Terms

Conditions

Colonic NeoplasmsRectal Neoplasms

Interventions

Early Intervention, EducationalMethods

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesInvestigative Techniques

Study Officials

  • Mira Katz

    Ohio State University Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 26, 2013

First Posted

February 28, 2013

Study Start

September 1, 2007

Primary Completion

August 1, 2010

Study Completion

December 1, 2010

Last Updated

October 16, 2014

Record last verified: 2014-10

Locations